- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Pasithea Therapeutics (KTTA)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 4.22 mm | 4.22 mm | 4.22 mm | 4.22 mm | 4.22 mm | 4.22 mm |
| Cash burn (monthly) | 997.83 k | 428.13 k | 1.04 mm | 1.16 mm | 963.34 k | 1.02 mm |
| Cash used (since last report) | 2.41 mm | 1.03 mm | 2.50 mm | 2.79 mm | 2.33 mm | 2.47 mm |
| Cash remaining | 1.81 mm | 3.19 mm | 1.72 mm | 1.43 mm | 1.90 mm | 1.76 mm |
| Runway (months of cash) | 1.8 | 7.4 | 1.7 | 1.2 | 2.0 | 1.7 |
| 13F holders | Current |
|---|---|
| Total holders | 13 |
| Opened positions | 10 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 259.94 mm |
| Total shares | 5.71 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Paul B Manning | 3.41 mm | $3.30 mm |
| IOI Ionic Ventures | 870.27 k | $1.54 mm |
| Alpha Capital Anstalt | 715.00 k | $1.27 mm |
| Kepos Capital | 334.60 k | $12.00 k |
| Warberg Asset Management | 254.70 k | $8.81 mm |
| Armistice Capital | 111.00 k | $193.88 mm |
| UBS UBS | 12.87 k | $40.53 mm |
| Tower Research Capital | 1.89 k | $5.94 mm |
| MS Morgan Stanley | 1.00 k | $3.15 mm |
| RY Royal Bank of Canada | 250.00 | $1.00 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Nov 25 | Emer Leahy | Common Stock | Grant | Acquire A | No | No | 0.75 | 33,333 | 25.00 k | 33,333 |
| 28 Nov 25 | Simon Dumesnil | Common Stock | Buy | Acquire P | No | No | 0.75 | 33,333 | 25.00 k | 35,833 |
| 28 Nov 25 | Tiago Marques | Common Stock | Buy | Acquire P | No | No | 0.75 | 33,333 | 25.00 k | 73,334 |
| 28 Nov 25 | Schneiderman Daniel H | Common Stock | Grant | Acquire A | No | No | 0.75 | 26,667 | 20.00 k | 26,667 |
| 28 Nov 25 | Lawrence Steinman | Common Stock | Buy | Acquire P | No | No | 0.75 | 133,333 | 100.00 k | 199,691 |